logo
logo
AI

Discover the World’s Fastest Business Insights

Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.

Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer

Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer

11/16/20, 8:09 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/GB.svgstevenage
Money raised
£4 million
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer, today unveiled an initial £4.5 million in seed financing from experienced venture investors, Sofinnova Partners and Brandon Capital Partners.

Company Info

Company
Myricx Pharma
Location
stevenage, england, united kingdom
Additional Info
About Myricx Pharma - http://www.myricxpharma.com
G2 High Performer Badge

Never Miss an Opportunity: Your #1 Sales Intelligence Tool

Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.